FindTrial
Sign In

TO EVALUATE THE EFFICIENCY OF MUSTADI KWATHA IN THE MANAGEMENT OF VATARAKTA WITH REFERENCE TO GOUT .

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Mustadi Kwatha in Management of Vatarakta with Special Reference to Gout. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107421
Enrollment
60
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Shiva Trusts Yashwantrao Chavan Ayurvedic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing the classical sign and symptoms of Vatarakta Patients between 16 to 70 years of Age Patients with raised uric acid 6.8 to 8

Exclusion criteria

Exclusion criteria: Patients below age 16 yrs and above 70 yrs . Long standing chronic cases of vatarakta with upadravas of vataratka Pregnant and lactating females. Any other illness like Diabetes mellitus, Tuberculosis, Leprosy, HIV, HbsAg and life threatning disorders ,etc

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Mustadi kwatha in management of Vatarakta with special reference to GoutTimepoint: 21 days—

Secondary

MeasureTime frame
To compare the reasults between mustadi kwatha and kokilakshadi kwatha in the management of goutTimepoint: 21 days—

Countries

India

Contacts

Public ContactDr Sandeep Kamble

Shiva Trusts Yashwantrao Chavan Ayurvedic Medical College and Hospital

ksandeep1983.sk@gmail.com9827994823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026